Umbilical cord blood stem cells: towards a proteomic approach.

@article{DAlessandro2010UmbilicalCB,
  title={Umbilical cord blood stem cells: towards a proteomic approach.},
  author={A. D’Alessandro and G. Liumbruno and G. Grazzini and S. Pupella and L. Lombardini and L. Zolla},
  journal={Journal of proteomics},
  year={2010},
  volume={73 3},
  pages={
          468-82
        }
}
The first umbilical cord blood (UCB) transplant to a sibling with Fanconi's anaemia in 1988 represented a breakthrough in the field of transplantation. Thereon, several transplants have been performed with UCB-derived hematopoietic stem cells (HSCs) and a plethora of studies have investigated the plasticity of UCB-derived stem and progenitor cells. However, these studies have not been hitherto translated into clinical trials and, although UCB is routinely used as an alternative source of HSCs… Expand
In Silico Analyses of Proteomic Data Suggest a Role for Heat Shock Proteins in Umbilical Cord Blood Hematopoietic Stem Cells
TLDR
It appears that maturation, other than representing a bottleneck to protein expression, could sculpt interaction maps via reducing complexity of immature interactomics profiles, in order to individuate main classes of proteins governing functioning of these cells. Expand
Proteomic Profiling of Ex Vivo Expanded CD34-Positive Haematopoetic Cells Derived from Umbilical Cord Blood
TLDR
Despite the fact that haematopoetic cells still expressed CD34 on the surface after 3 days, major changes in regard to the protein profile were observed, while further expansion showed less effect on the proteome level. Expand
Comparative proteomic analysis of endothelial cells progenitor cells derived from cord blood- and peripheral blood for cell therapy.
TLDR
The results suggest that specifically up-regulated factors such as STMIN 1, CFL 1, PARK 7, NME 1, GLO 1, HSP 27 and PRDX 2 in CB-EPCs as key elements that could be functionally active in ischemic regions and that CB- EPCs may be more appropriate for inducing neo-vessels. Expand
How has proteomics informed transfusion biology so far?
TLDR
Proteomics investigations could be potentially used from bench to bedside, in order to test the quality of collected blood components prior to or during storage, and to verify the effects of the production and pathogen reduction processes of plasma derivatives and blood components on the protein fractions. Expand
The requirement for proteomics to unravel stem cell regulatory mechanisms
TLDR
The phenomenon of induced pluripotency via cellular reprogramming also can be understood optimally using combined molecular biology and proteomics approaches, and current research employing proteomics and mass spectrometry to dissect stem cell regulatory mechanisms is described. Expand
Clinical metabolomics: the next stage of clinical biochemistry.
Centuries of scientific advances have paved the way for the relatively recent great strides in clinical biochemistry, a field which mainly relies upon biochemical analyses of various body fluids,Expand
Novel therapeutic strategies for prevention of postresectional liver failure
TLDR
MonoHER prevented MCT induced portal hypertension and hepatic injury in rats and is an effective method for longitudinal monitoring of distribution, survival and engraftment of transplanted cells. Expand
Blood and Plasma Proteomics: Targeted Quantitation and Posttranslational Redox Modifications.
TLDR
The design and production of heavy isotope-labeled peptides used as reporter internal standards for absolute protein quantification and a redox proteomics approach to optimize sample preparation and database searching to elucidate oxidative modifications to protein amino acids are described. Expand
Regulation of cell-based therapeutic products intended for human applications in the EU.
TLDR
The results indicate that the regulatory burden of a CBTP is related to the risk it may pose to the health and safety of recipients, and the current framework does not cover all possible CBTPs. Expand
Characterization of polysaccharide from Astragalus radix as the macrophage stimulator.
TLDR
The results suggested that APS possess potent immunomodulatory activity by stimulating macrophage and could be used as an immunotherapeutic adjuvant. Expand
...
1
2
...

References

SHOWING 1-10 OF 183 REFERENCES
Umbilical cord blood transplantation: pros, cons and beyond.
TLDR
Results of recent international studies indicate that in particular clinical settings, such as in children with leukemia, CB may become a frontline hematopoietic stem cell (HSC) source for transplantation. Expand
Banking strategies for improving the hematopoietic stem cell content of umbilical cord blood units for transplantation.
TLDR
This bank selected the UCB units for cryopreservation on the basis of their total nucleated cells (TNC) and CD34(+) cells content and also reviewed the results of their UCB bank program. Expand
Ex vivo expansion of umbilical cord blood stem cells for transplantation: growing knowledge from the hematopoietic niche
TLDR
The future of ex vivo expansion of UCBT will include the isolation of immature hematopoietic progenitors on the basis of function rather than surface phenotype and will employ both cytokines and stroma to maintain and expand the stem cell niche. Expand
The potential of umbilical cord blood multipotent stem cells for nonhematopoietic tissue and cell regeneration.
TLDR
This review will summarize the in vitro and in vivo studies examining UCB stem cells and their potential use for therapeutic application for nonhematopoietic tissue and cell regeneration. Expand
Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System.
TLDR
Clinical-scale ex vivo expansion of UCB is feasible, and the administration of ex vivo-expanded cells is well tolerated, and a randomized phase 2 study will determine whether augmenting conventional UCB transplants with ex vivo -expanded UCB cells is beneficial. Expand
Umbilical cord blood stem cells.
  • I. Rogers, R. Casper
  • Medicine
  • Best practice & research. Clinical obstetrics & gynaecology
  • 2004
The umbilical cord contains a rich source of haematopoietic stem cells that can be used to reconstitute the blood system and can easily be extracted and cryopreserved, thus allowing for theExpand
Optimization of immunomagnetic separation for cord blood-derived hematopoietic stem cells
TLDR
Investigation of immunomagnetic cell sorting protocols to purify CD34+, CD133+ and Lin- cells from fresh and cryopreserved cord blood found them to be highly viable having substantial colony-forming potential and enable rapid enrichment of highly pure hematopoietic stem cells. Expand
Umbilical cord blood banking and transplantation
TLDR
Results of the analysis show that cord blood hematopoietic stem cells are a good alternative to bone marrow hematoplastic stem cells in children and in adults with hematologic malignant and non malignant diseases. Expand
Mesenchymal progenitor cells in human umbilical cord blood
TLDR
The results suggest that preterm, as compared with term, cord blood is richer in mesenchymal progenitors, similar to haematopoietic progenitor cells. Expand
New insights into cord blood stem cell transplantation
TLDR
Umbilical cord blood is a valuable alternative source of hematopoietic stem cells for patients that require allogeneic transplantation in the absence of readily available human leukocyte antigen matched marrow or blood hematoplastic stem cells. Expand
...
1
2
3
4
5
...